Dynavax Technologies Corp (DVAX)

16.16 +0.09  +0.56% NASDAQ Nov 30, 16:00 16.16 0.00  0.00% After-Hours: 20:00 USD
View Full Chart
Price Chart
View All DVAX News

News

View All Events

Events

Date Type Description
02/25/2022 Earnings Results Q4 2021 Earnings Results
02/25/2022 16:30 EST Earnings Calls Q4 2021 Earnings Call
11/04/2021 Earnings Results Q3 2021 Earnings Results
11/04/2021 16:30 EST Earnings Calls Q3 2021 Earnings Call
08/04/2021 Earnings Results Q2 2021 Earnings Results
08/04/2021 16:30 EST Earnings Calls Q2 2021 Earnings Call
05/28/2021 12:00 EST AGM 2020 Annual General Meeting
05/06/2021 Earnings Results Q1 2021 Earnings Results
05/06/2021 16:30 EST Earnings Calls Q1 2021 Earnings Call
02/25/2021 Earnings Results Q4 2020 Earnings Results
View All Performance Charts

Total Returns Comparison

Ratings & Reports

Advertisement
Edit

Profile

  • Description: Dynavax Technologies Corp is a biopharmaceutical company. The company focuses on leveraging the power of the body's innate and adaptive immune responses through toll-like receptor stimulation. Its current product candidates are being investigated for use in multiple cancer indications as a vaccine for the prevention of hepatitis B. Dynavax operates in the business segment of discovery, development, and commercialization of novel vaccines. Its Toll-like Receptor Immune Modulation Platform technology plays a vital role in innate immunity and subsequent adaptive immunity. The company generates the vast majority of its revenue from the sale of its HEPLISAV-B product.
  • URL: https://www.dynavax.com
  • Investor Relations URL: https://investors.dynavax.com
  • HQ State/Province: California
  • Sector: Healthcare
  • Industry: Drug Manufacturers - Specialty & Generic
  • Equity Style: Small Cap/Growth
  • Next Earnings Release: Feb. 25, 2022
  • Last Earnings Release: Nov. 04, 2021
  • Next Ex-Dividend Date: N/A
  • Last Ex-Dividend Date: N/A

Top Fund Holders

Symbol Name Weighting
HVAX.TO Horizons Global Vaccines & Infect DisETF 4.17%
PBE Invesco Dynamic Biotech & Genome ETF 3.15%
KAUBX Federated Hermes Kaufmann B 1.74%
FKBSX Federated Hermes Kaufmann Small Cap B 1.57%
MIND.TO Horizons Active A.I. Global Equity ETF 1.27%
BBC Virtus LifeSci Biotech Clinical Trls ETF 1.20%
GERM ETFMG Treatments Testing and Adv ETF 1.11%
RYMCX Royce Micro-Cap Consult 1.00%
IWC iShares Micro-Cap ETF 0.34%

Comparables

Edit
Advertisement

{{root.upsell.info.feature_headline}}.

{{root.upsell.info.feature_description}}

Please note that this feature is only available as an add-on to YCharts subscriptions.


Please note that this feature requires full activation of your account and is not permitted during the free trial period.

Start My Free Trial {{root.upsell.info.call_to_action}} No credit card required.

Already a subscriber? Sign in.